These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30243152)

  • 21. Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.
    Shi J; Zhou J; Halambage UD; Shah VB; Burse MJ; Wu H; Blair WS; Butler SL; Aiken C
    J Virol; 2015 Jan; 89(1):208-19. PubMed ID: 25320302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
    Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
    J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
    Shi J; Zhou J; Shah VB; Aiken C; Whitby K
    J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
    Hulme AE; Kelley Z; Foley D; Hope TJ
    J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
    Yang J; Chen W; Kang D; Lu X; Li X; Liu Z; Huang B; Daelemans D; Pannecouque C; De Clercq E; Zhan P; Liu X
    Eur J Med Chem; 2016 Feb; 109():294-304. PubMed ID: 26802545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small molecule fusion inhibitors: design, synthesis and biological evaluation of (Z)-3-(5-(3-benzyl-4-oxo-2-thioxothiazolidinylidene)methyl)-N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrroles and related derivatives targeting HIV-1 gp41.
    He XY; Lu L; Qiu J; Zou P; Yu F; Jiang XK; Li L; Jiang S; Liu S; Xie L
    Bioorg Med Chem; 2013 Dec; 21(23):7539-48. PubMed ID: 23673219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
    Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel anti-HIV agents via Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry-based approach.
    Gao P; Sun L; Zhou J; Li X; Zhan P; Liu X
    Expert Opin Drug Discov; 2016 Sep; 11(9):857-71. PubMed ID: 27400283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators.
    Zhang X; Sun L; Xu S; Shao X; Li Z; Ding D; Jiang X; Zhao S; Cocklin S; Clercq E; Pannecouque C; Dick A; Liu X; Zhan P
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.
    Spearman P
    Curr Top Med Chem; 2016; 16(10):1154-66. PubMed ID: 26329615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules.
    Vernekar SKV; Sahani RL; Casey MC; Kankanala J; Wang L; Kirby KA; Du H; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32316297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization.
    Liu Z; Chen W; Zhan P; De Clercq E; Pannecouque C; Liu X
    Eur J Med Chem; 2014 Nov; 87():52-62. PubMed ID: 25240095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional label-free assays for characterizing the in vitro mechanism of action of small molecule modulators of capsid assembly.
    Lad L; Clancy S; Koditek D; Wong MH; Jin D; Niedziela-Majka A; Papalia GA; Hung M; Yant S; Somoza JR; Hu E; Chou C; Tse W; Halcomb R; Sakowicz R; Pagratis N
    Biochemistry; 2015 Apr; 54(13):2240-8. PubMed ID: 25774576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
    Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
    J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators.
    Xu S; Sun L; Zalloum WA; Huang T; Zhang X; Ding D; Shao X; Jiang X; Zhao F; Cocklin S; De Clercq E; Pannecouque C; Dick A; Liu X; Zhan P
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid.
    Chia T; Nakamura T; Amano M; Takamune N; Matsuoka M; Nakata H
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0103921. PubMed ID: 34228546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
    Machara A; Lux V; Kožíšek M; Grantz Šašková K; Štěpánek O; Kotora M; Parkan K; Pávová M; Glass B; Sehr P; Lewis J; Müller B; Kräusslich HG; Konvalinka J
    J Med Chem; 2016 Jan; 59(2):545-58. PubMed ID: 26685880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
    Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
    PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
    Meng Q; Chen X; Kang D; Huang B; Li W; Zhan P; Daelemans D; De Clercq E; Pannecouque C; Liu X
    Eur J Med Chem; 2016 Jun; 115():53-62. PubMed ID: 26994843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HIV-1 capsid protein as a drug target: recent advances and future prospects.
    Domenech R; Neira JL
    Curr Protein Pept Sci; 2013 Dec; 14(8):658-68. PubMed ID: 24106962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.